i. Gangadi Madhukar Reddy, is the Managing Director and Chief Executive Officer of the Company. He is one of the Promoters of the Company and has been a Director of the Company since incorporation on November 30, 2006. He holds a bachelor’s degree in medicine and surgery from the Sri Venkateswara University and a master’s degree in business administration from the Wharton School, University of Pennsylvania. In 2015, he was awarded the “Business Person of the Year – Large Scale” at the Sakshi Excellence Awards by Sakshi Media Group. ii. Anish Kumar Saraf, is a Non-Executive Director of the Company. He is a chartered accountant with the Institute of Chartered Accountants of India. He holds a post-graduate diploma in management from the Indian Institute of Management, Ahmedabad. He is the managing director of Warburg Pincus India Private Limited and has been in the employment of the company for 15 years. iii. Atul Gupta, is a Non-Executive Director of the Company. He holds a bachelor’s degree in technology from the Indian Institute of Technology, Bombay and a master’s degree in business administration from the Walter A. Haas School of Business, University of California, Berkeley. He is employed as an investment partner at Prazim Trading and Investment Company Private Limited. He has over 13 years of experience in the investment industry.

Particulars (in Millions)	2020-21	2019-20
Revenue	30,693	28,706
Cost of goods sold	25,213	25,806
Cost of materials consumed	82	38
Increase in inventories	-1,054	-2,479
Employee benefits expense	3,386	2,724
Net loss on fair value changes		322
Other Expense	897	956
Operating profit	2,167	1,336.78
OPM %	7%	5%
Other Income	215	172
Finance Cost	548	467
Depriciation	882	748
Profit Before tax	950	293
Profit After Tax	640	-5.36
EPS	30	1.05

Total Outstanding Shares before IPO = 111,761,165 New Shares to be issued in IPO = 75,37,688 Total Shares Outstanding after IPO = 119,298,853 PAT (FY21) = 64 Crores EPS(FY21) = 5.33 P/E = 796/5.33 = 150x

There are no listed companies in India that comparable in all aspects of business and services of Medplus.

Review and Recommendation of Medplus by InvestorZone is 4/10 1. It is the second largest Retail Pharmacy chain in India after Apollo. They also sell medicines via Online Channel. 2. Medplus is a having lean Cost Structure and technology driven Operations. 3. Medplus has well qualified, experienced and entrepreneurial board and senior management team. 4. This is the first IPO of Retail Pharmacy Chain, so difficult to comment on valuation. 5. Mcap at which IPO is coming = 9400 Crores. Sales of FY21 = 3100 Crores. Mcap/Sales = 3x (Looks Fairly Priced)

Medplus Health Services Limited 707, 7th Floor, 5-9-13, Taramandal Commercial Complex, Saifabad Hyderabad 500 004 Phone: +91 040 6724 6724 Email: cs@medplusindia.com Website: http://www.medplusindia.com/